DRUGS RETAINED IN TARGET TISSUE OVER LONG TIME
Provided are a polyethylene glycol-bound ligand in which a polyethylene glycol chain is bound to a ligand having a binding affinity to a specific receptor or a protein such as an antigen or the like present on a cell membrane of a target tissue and having an ability to avoid internalization (incorpo...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided are a polyethylene glycol-bound ligand in which a polyethylene glycol chain is bound to a ligand having a binding affinity to a specific receptor or a protein such as an antigen or the like present on a cell membrane of a target tissue and having an ability to avoid internalization (incorporation) into cells and a medicament in which a drug such as a physiologically active protein or the like is bound to the polyethylene glycol chain thereof. A novel ligand which is accumulated at a high concentration around a target tissue and has a high retention property in blood and an excellent medicament in which a drug effective for the target tissue, such as a physiologically active protein or the like, is introduced therein can be provided. |
---|